Scientists discover potential new targets for Alzheimer’s drugs
Pathways involved in DNA repair and other cellular functions could contribute to the development of Alzheimer’s.
Pathways involved in DNA repair and other cellular functions could contribute to the development of Alzheimer’s.
One combination of methods led to a 44 percent increase in child immunizations.
Trained with a joint understanding of protein and cell behavior, the model could help with diagnosing disease and developing new drugs.
MIT engineers designed polymer microparticles that can deliver vaccines at predetermined times after injection.
Words like “no” and “not” can cause this popular class of AI models to fail unexpectedly in high-stakes settings, such as medical diagnosis.
Their study yielded hundreds of “cryptic” peptides that are found only on pancreatic tumor cells and could be targeted by vaccines or engineered T cells.
A new book coauthored by MIT’s Dimitris Bertsimas explores how analytics is driving decisions and outcomes in health care.
MIT chemists found a way to identify a complex sugar molecule in the cell walls of Mycobacterium tuberculosis, the world’s deadliest pathogen.
During the early teen years, many new strains of C. acnes colonize the skin on our faces. This could be an optimal time for probiotic treatment.
A new method helps convey uncertainty more precisely, which could give researchers and medical clinicians better information to make decisions.
Clinical trial finds several outcomes improved for young children when an anesthesiologist observed their brain waves to guide dosing of sevoflurane during surgery.
Ultraviolet light “fingerprints” on cell cultures and machine learning can provide a definitive yes/no contamination assessment within 30 minutes.
Moving Health has developed an emergency transportation network using motorized ambulances in rural regions of Ghana.
Founded by MIT researchers, Senti Bio is giving immune cells the ability to distinguish between healthy and cancerous cells.
A comprehensive study of the U.S. system could help policymakers analyze methods of matching donated kidneys and their recipients.